Commodore Capital LP Sells in Q3 2024

Commodore Capital LP

  • $1.18 Billion
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
ARVN
Arvinas, Inc.

Healthcare
-684K
- 36.32%
$23.66 - $32.73 $16.2M - $22.4M
1.2M $29.6M
NUVL
Nuvalent, Inc.

Healthcare
-548K
- 36.82%
$67.44 - $112.17 $36.9M - $61.4M
940K $96.2M
RYTM
Rhythm Pharmaceuticals, Inc.

Healthcare
-575K
- 46.94%
$40.81 - $55.0 $23.5M - $31.6M
650K $34.1M
THRD
Third Harmonic Bio, Inc.

Healthcare
-185K
- 11.96%
$10.86 - $15.0 $2.01M - $2.77M
1.36M $18.4M
XENE
Xenon Pharmaceuticals Inc.

Healthcare
-54.3K
- 1.97%
$36.12 - $43.96 $1.96M - $2.39M
2.7M $106M
COGT
Cogent Biosciences, Inc.

Healthcare
-2.2M
- 22.57%
$8.24 - $11.48 $18.1M - $25.2M
7.54M $81.4M
Perspective Therapeutics Inc
-1.31M
- 28.07%
N/A
3.35M $0
Soleno Therapeutics Inc
-165K
- 11.58%
N/A
1.26M $0
PCVX
Vaxcyte, Inc.

Healthcare
-385K
- 29.5%
$70.52 - $117.12 $27.2M - $45.1M
920K $105M
Activity Summary
Buys All Purchases 16 New Holdings 4 Increased Positions 12 Sells All Sells 9 Reductions 9 Sold out 0 Options Calls 0 Puts 0
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email